dalteparin has been researched along with Esophageal and Gastric Varices in 6 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Esophageal and Gastric Varices: Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "SVT favors the relapse of esophageal varices, but rebleeding can be effectively prevented by standard scheduled band ligations." | 1.38 | Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis. ( Amitrano, L; Guardascione, MA; Lampasi, F; Lanza, AG; Manguso, F; Martino, R; Menchise, A; Scaglione, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z | 1 |
| Li, S | 1 |
| Zhao, J | 1 |
| Li, J | 1 |
| Gao, Y | 1 |
| Bechmann, LP | 2 |
| Sichau, M | 1 |
| Wichert, M | 2 |
| Gerken, G | 1 |
| Kröger, K | 2 |
| Hilgard, P | 2 |
| Northup, PG | 1 |
| Intagliata, NM | 1 |
| Lisman, T | 1 |
| Porte, RJ | 1 |
| Amitrano, L | 1 |
| Guardascione, MA | 1 |
| Scaglione, M | 1 |
| Menchise, A | 1 |
| Martino, R | 1 |
| Manguso, F | 1 |
| Lanza, AG | 1 |
| Lampasi, F | 1 |
1 trial available for dalteparin and Esophageal and Gastric Varices
| Article | Year |
|---|---|
Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
Topics: Albumins; Anticoagulants; Esophageal and Gastric Varices; Fibrosis; Gastrointestinal Hemorrhage; Hum | 2023 |
5 other studies available for dalteparin and Esophageal and Gastric Varices
| Article | Year |
|---|---|
Low-molecular-weight heparin in patients with advanced cirrhosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Blood Coagulation; Dru | 2011 |
Anticoagulation in cirrhosis patients: what don't we know?
Topics: Anticoagulants; Antithrombin III; Blood Coagulation; Drug Monitoring; Enoxaparin; Esophageal and Gas | 2011 |
Towards a rational use of low-molecular-weight heparin in patients with cirrhosis.
Topics: Anticoagulants; Blood Coagulation; Enoxaparin; Esophageal and Gastric Varices; Female; Humans; Liver | 2011 |
Dosing and monitoring of low-molecular-weight heparin in cirrhotic patients.
Topics: Anticoagulants; Blood Coagulation; Enoxaparin; Esophageal and Gastric Varices; Female; Humans; Liver | 2011 |
Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis.
Topics: Aged; Anticoagulants; Chi-Square Distribution; Endoscopy, Gastrointestinal; Enoxaparin; Esophageal a | 2012 |